<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) APRIL 20, 2000
OCULAR SCIENCES, INC.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
DELAWARE
- --------------------------------------------------------------------------------
(State or Other Jurisdiction)
000-22623 94-2985696
- --------------------------------------------------------------------------------
(Commission File Number) (IRS Employer Identification No.)
475 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA 94080
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(650) 583-1400
- --------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
NOT APPLICABLE
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
ITEM 5. OTHER EVENTS.
On April 20, 2000, the Registrant ("Ocular Sciences") announced that
Norwick B.H. Goodspeed, President and Chief Executive Officer, and Gregory E.
Lichtwardt, Vice President, Finance and Chief Financial Officer, would be
leaving Ocular Sciences. Mr. Goodspeed's resignation as an officer and director
of Ocular Sciences was effective April 20, 2000 and Mr. Lichtwardt's resignation
as an officer of Ocular Sciences will become effective May 5, 2000. John D.
Fruth, Ocular Sciences' Chairman, founder and former Chief Executive Officer,
has filled Mr. Goodspeed's officer positions since April 20, 2000. Mr.
Lichtwardt's positions will be filled on an interim basis by Edgar J. Cummins, a
member of Ocular Sciences' board of directors since 1992 and former Chief
Financial Officer of Allergan, Inc.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
OCULAR SCIENCES, INC.
--------------------------------------------
(Registrant)
Date: April 28, 2000 By: /s/ JOHN D. FRUTH
----------------------------------------
Name: John D. Fruth
Title: Chairman and Chief Executive Officer
--------------------------------------------
(Signature)(1)
- ---------------------
(1) Print the name and title of the signing officer under his signature.
3
